- Patent Title: Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
-
Application No.: US16432228Application Date: 2019-06-05
-
Publication No.: US10562884B2Publication Date: 2020-02-18
- Inventor: Sangdon Han , Yunfei Zhu , Sun Hee Kim , Jian Zhao , Shimiao Wang
- Applicant: Crinetics Pharmaceuticals, Inc.
- Applicant Address: US CA San Diego
- Assignee: CRINETICS PHARMACEUTICALS, INC.
- Current Assignee: CRINETICS PHARMACEUTICALS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D295/04 ; C07D401/10 ; C07D407/14

Abstract:
Described herein are compounds that are melanocortin subtype-2 receptor (MC2R) modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of MC2R activity.
Public/Granted literature
- US20190367481A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Public/Granted day:2019-12-05
Information query